UG Healthcare Corporation Limited
SGX:8K7.SI
0.109 (SGD) • At close May 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) SGD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 115.205 | 101.133 | 232.598 | 338.401 | 144.209 | 91.712 | 78.06 | 65.239 | 58.823 | 55.74 | 49.009 |
| Cost of Revenue
| 89.339 | 99.685 | 148.212 | 142.241 | 101.69 | 72.996 | 65.296 | 55.573 | 46.13 | 44.191 | 38.807 |
| Gross Profit
| 25.866 | 1.448 | 84.386 | 196.16 | 42.519 | 18.716 | 12.764 | 9.666 | 12.693 | 11.549 | 10.202 |
| Gross Profit Ratio
| 0.225 | 0.014 | 0.363 | 0.58 | 0.295 | 0.204 | 0.164 | 0.148 | 0.216 | 0.207 | 0.208 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 24.01 | 20.066 | 25.475 | 33.066 | 13.715 | 12.27 | 8.853 | 6.576 | 6.738 | 6.859 | 4.275 |
| Selling & Marketing Expenses
| 8.484 | 6.501 | 7.745 | 7.308 | 4.003 | 2.815 | 1.8 | 1.784 | 1.334 | 1.332 | 0.343 |
| SG&A
| 32.494 | 26.567 | 33.22 | 40.374 | 17.718 | 15.085 | 10.653 | 8.36 | 8.072 | 8.191 | 4.618 |
| Other Expenses
| 0 | -5.427 | -2.148 | -0.459 | -6.07 | -1.651 | -1.12 | -0.506 | -0.046 | -0.961 | 0 |
| Operating Expenses
| 32.494 | 26.567 | 33.22 | 40.374 | 17.718 | 15.085 | 10.653 | 8.36 | 8.06 | 8.156 | 4.56 |
| Operating Income
| -6.628 | -25.119 | 49.544 | 160.007 | 20.042 | 3.642 | 5.797 | 3.199 | 7 | 3.791 | 5.851 |
| Operating Income Ratio
| -0.058 | -0.248 | 0.213 | 0.473 | 0.139 | 0.04 | 0.074 | 0.049 | 0.119 | 0.068 | 0.119 |
| Total Other Income Expenses Net
| -2.461 | -3.242 | -0.783 | -4.183 | -1.985 | -0.868 | -0.75 | -0.63 | 2.848 | 0.166 | 0.279 |
| Income Before Tax
| -9.089 | -28.918 | 48.761 | 159.403 | 18.057 | 2.763 | 5.047 | 2.569 | 7.469 | 3.957 | 6.13 |
| Income Before Tax Ratio
| -0.079 | -0.286 | 0.21 | 0.471 | 0.125 | 0.03 | 0.065 | 0.039 | 0.127 | 0.071 | 0.125 |
| Income Tax Expense
| -0.308 | -1.398 | 8.963 | 39.459 | 2.971 | 0.546 | 0.734 | 0.389 | 1.95 | 1.025 | 1.218 |
| Net Income
| -6.056 | -20.734 | 36.795 | 118.765 | 13.402 | 2.507 | 4.335 | 2.444 | 5.45 | 3.164 | 4.9 |
| Net Income Ratio
| -0.053 | -0.205 | 0.158 | 0.351 | 0.093 | 0.027 | 0.056 | 0.037 | 0.093 | 0.057 | 0.1 |
| EPS
| -0.01 | -0.033 | 0.059 | 0.19 | 0.023 | 0.004 | 0.008 | 0.004 | 0.01 | 0.006 | 0.009 |
| EPS Diluted
| -0.01 | -0.033 | 0.059 | 0.19 | 0.023 | 0.004 | 0.008 | 0.004 | 0.01 | 0.006 | 0.009 |
| EBITDA
| -3.858 | -24.529 | 53.373 | 159.463 | 21.348 | 6.004 | 7.246 | 4.432 | 8.706 | 5.221 | 7.247 |
| EBITDA Ratio
| -0.033 | -0.243 | 0.229 | 0.471 | 0.148 | 0.065 | 0.093 | 0.068 | 0.148 | 0.094 | 0.148 |